Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target. (2018)

First Author: Apps JR
Attributed to:  BRain Archive Information Network (BRAIN UK) funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00401-018-1830-2

PubMed Identifier: 29541918

Publication URI: http://europepmc.org/abstract/MED/29541918

Type: Journal Article/Review

Volume: 135

Parent Publication: Acta neuropathologica

Issue: 5

ISSN: 0001-6322